News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,136 Results
Type
Article (41057)
Company Profile (275)
Press Release (665804)
Multimedia
Podcasts (56)
Webinars (12)
Section
Business (206502)
Career Advice (2015)
Deals (35746)
Drug Delivery (97)
Drug Development (82386)
Employer Resources (172)
FDA (16343)
Job Trends (15020)
News (349245)
Policy (32821)
Tag
Academia (2602)
Accelerated approval (5)
Adcomms (23)
Allergies (85)
Alliances (50258)
ALS (89)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (141)
Approvals (16345)
Artificial intelligence (265)
Autoimmune disease (22)
Automation (16)
Bankruptcy (361)
Best Places to Work (11781)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (199)
Bladder cancer (83)
Brain cancer (29)
Breast cancer (286)
Cancer (2352)
Cardiovascular disease (174)
Career advice (1684)
Career pathing (30)
CAR-T (159)
Cell therapy (439)
Cervical cancer (20)
Clinical research (67053)
Collaboration (853)
Company closure (1)
Compensation (539)
Complete response letters (20)
COVID-19 (2603)
CRISPR (41)
C-suite (249)
Cystic fibrosis (100)
Data (2223)
Decentralized trials (2)
Denatured (18)
Depression (44)
Diabetes (270)
Diagnostics (6449)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (87194)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (114406)
Executive appointments (733)
FDA (17618)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (757)
Gene editing (106)
Generative AI (23)
Gene therapy (306)
GLP-1 (718)
Government (4449)
Grass and pollen (4)
Guidances (67)
Healthcare (19098)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (121)
Indications (29)
Infectious disease (2747)
Inflammatory bowel disease (139)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (97)
Interviews (311)
IPO (16638)
IRA (41)
Job creations (3657)
Job search strategy (1430)
Kidney cancer (11)
Labor market (38)
Layoffs (486)
Leadership (17)
Legal (7946)
Liver cancer (78)
Lung cancer (337)
Lymphoma (155)
Machine learning (7)
Management (58)
Manufacturing (306)
MASH (67)
Medical device (13435)
Medtech (13440)
Mergers & acquisitions (19655)
Metabolic disorders (688)
Multiple sclerosis (81)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1924)
NextGen: Class of 2025 (6594)
Non-profit (4536)
Now hiring (39)
Obesity (367)
Opinion (210)
Ovarian cancer (77)
Pain (87)
Pancreatic cancer (84)
Parkinson's disease (149)
Partnered (21)
Patents (235)
Patient recruitment (114)
Peanut (46)
People (58092)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20953)
Phase II (29507)
Phase III (22015)
Pipeline (1213)
Policy (140)
Postmarket research (2594)
Preclinical (8874)
Press Release (64)
Prostate cancer (111)
Psychedelics (31)
Radiopharmaceuticals (258)
Rare diseases (380)
Real estate (5969)
Recruiting (65)
Regulatory (22519)
Reports (46)
Research institute (2374)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (71)
Series A (134)
Series B (86)
Service/supplier (11)
Sickle cell disease (53)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3643)
State (2)
Stomach cancer (15)
Supply chain (68)
Tariffs (40)
The Weekly (36)
Vaccines (701)
Venture capitalists (41)
Weight loss (237)
Women's health (35)
Worklife (16)
Date
Today (141)
Last 7 days (906)
Last 30 days (2667)
Last 365 days (33112)
2025 (10885)
2024 (35685)
2023 (40512)
2022 (51707)
2021 (56240)
2020 (54575)
2019 (47133)
2018 (35513)
2017 (32662)
2016 (32069)
2015 (38087)
2014 (31759)
2013 (26732)
2012 (28937)
2011 (29671)
2010 (27628)
Location
Africa (728)
Alabama (58)
Alaska (7)
Arizona (232)
Arkansas (14)
Asia (38608)
Australia (6315)
California (6175)
Canada (2022)
China (534)
Colorado (267)
Connecticut (275)
Delaware (149)
Europe (83948)
Florida (913)
Georgia (208)
Idaho (58)
Illinois (546)
India (25)
Indiana (309)
Iowa (11)
Japan (165)
Kansas (105)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (905)
Massachusetts (4666)
Michigan (220)
Minnesota (396)
Mississippi (2)
Missouri (81)
Montana (29)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1735)
New Mexico (28)
New York (1757)
North Carolina (977)
North Dakota (8)
Northern California (2695)
Ohio (205)
Oklahoma (14)
Oregon (34)
Pennsylvania (1387)
Puerto Rico (12)
Rhode Island (33)
South America (1110)
South Carolina (23)
South Dakota (1)
Southern California (2314)
Tennessee (102)
Texas (914)
United States (23351)
Utah (180)
Virginia (146)
Washington D.C. (63)
Washington State (555)
West Virginia (3)
Wisconsin (55)
707,136 Results for "champions oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Champions Oncology’s Data Platform Gains Momentum through a Strategic Collaboration with Turbine
April 24, 2025
·
4 min read
Press Releases
Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
April 29, 2025
·
2 min read
Press Releases
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million
March 12, 2025
·
14 min read
Press Releases
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025
March 6, 2025
·
1 min read
Business
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
Champions Oncology, Inc., a leader in the development of advanced preclinical oncology solutions, has announced a strategic partnership with Medicines Discovery Catapult, enhancing their combined capabilities in the expanding field of radiopharmaceutical therapeutics.
June 4, 2024
·
3 min read
Press Releases
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
February 18, 2025
·
1 min read
Drug Development
Diversity at the Forefront: Life Sciences Industry Champions Inclusive Representation
The industry remains unwavering in the commitment to increased clinical trial accessibility and representation.
February 25, 2025
·
1 min read
·
Lori Ellis
Press Releases
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
January 9, 2025
·
2 min read
Business
Champions Oncology Reports Quarterly Revenue of $12.0 Million
Champions Oncology, Inc., a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announced its financial results for its third quarter of fiscal 2024, ended January 31, 2024.
March 12, 2024
·
12 min read
Policy
Champions Oncology’s US Laboratory has Acquired Distinguished CAP Accreditation
Champions Oncology, Inc., a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announced that the College of American Pathologists has awarded accreditation to its US-based laboratory.
March 7, 2024
·
2 min read
1 of 70,714
Next
